Michail Mavros, MD

Research Program: Cancer Prevention and Population Sciences Faculty Rank: Assistant Professor Campus: University of Arkansas for Medical Sciences College: College of Medicine Department: Surgery

Cancer Research Interest

• Disease Site Focus: GI, Sarcoma, Melanoma
• Research Focus Area: Treatment, Diagnosis/ Prognosis, Informatics
• Type of Research: Population Sciences, Clinical
• Research Keywords: clinical outcomes, health services
• Research Interest Statement: Access to care (disparities, improving access), clinical outcomes of cancer patients

Contact Information

• Email Address: MMAVROS@UAMS.EDU
• Profiles Research Networking Software: View Profile

Open Clinical Trials

• “S2015 Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigation 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma” (NCT03860883)
• “EA2197 Optimal Perioperative Therapy For Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial” (NCT04559139)

Publications

• Vawter K, Kuhn S, Pitt H, [et al., including Mavros MN]. Complications and failure-to-rescue after pancreatectomy and hospital participation in the targeted American College of Surgeons National Surgical Quality Improvement Program registry. Surgery. 2023 174(5):1235-1240. PMID: 37612210. PMCID: PMC10592020.
• Mavros MN, Johnson LA, Schootman M, [et al.]. Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery. Annals of surgical oncology. 2023 30(9):5522-5531. PMID: 37338748. PMCID: PMC10409669.
• Mavros MN, Johnson LA, Schootman M, [et al.]. ASO Visual Abstract: Adherence to and Outcomes of Extended Venous Thromboembolism Prophylaxis After Complex Gastrointestinal Oncologic Surgery. Annals of surgical oncology. 2023 30(9):5532-5533. PMID: 37428329.
• Osborn TA, Bennett JL, Jensen HK, [et al., including Mavros MN]. Morbidity of colectomy during pancreatoduodenectomy: An analysis of the pancreas-targeted American College of Surgeons National Surgical Quality Improvement Program Registry. Journal of hepato-biliary-pancreatic sciences. 2022. PMID: 36282586.
• Walker RJB, Look Hong NJ, Moncrieff M, [et al., including Mavros MN]. ASO Visual Abstract: Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma-An International Multi-institutional Collaboration. Annals of surgical oncology. 2022. PMID: 35810221.
• Walker RJB, Look Hong NJ, Moncrieff M, [et al., including Mavros MN]. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration. Annals of surgical oncology. 2022. PMID: 35676603.
• Khorsandi SE, Hardgrave HJ, Osborn T, [et al., including Mavros MN]. Artificial Intelligence in Liver Transplantation. Transplantation proceedings. 2021 53(10):2939-2944. PMID: 34740449.
• Mavros MN, Coburn NG, Davis LE, [et al.]. Risk of venous thromboembolism in patients with elevated INR undergoing hepatectomy: an analysis of the American college of surgeons national surgical quality improvement program registry. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2021 23(7):1008-1015. PMID: 33177005.
• Mavros MN, Moris D, Karanicolas PJ, [et al.]. Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review. JAMA surgery. 2021 156(7):663-672. PMID: 33787841.
• Esagian SM, Kakos CD, Giorgakis E, [et al., including Mavros MN]. Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers. 2021 13(12). PMID: 34203692. PMCID: PMC8232114.
• Mavros MN, Davis LE, Hallet J, [et al.]. Symptom Burden of Nonresected Pancreatic Adenocarcinoma: An Analysis of 10,753 Patient-Reported Outcome Assessments. Pancreas. 2020 49(8):1083-1089. PMID: 32769858.
• Hallet J, Davis L, Mahar A, [et al., including Mavros M]. Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis. Journal of the National Comprehensive Cancer Network : JNCCN. 2020 18(3):297-303. PMID: 32135510.
• Tung S, Davis LE, Hallet J, [et al., including Mavros MN]. Population-Level Symptom Assessment Following Pancreaticoduodenectomy for Adenocarcinoma. JAMA surgery. 2019 154(11):e193348. PMID: 31483457. PMCID: PMC6727685.
• Mavros MN, Theochari NA, Kyriakidou M, [et al.]. Fluoroquinolone-based versus β-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents. 2019 53(6):746-754. PMID: 30639629.
• Mavros MN, Coburn NG, Davis LE, [et al.]. Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2019 191(21):E574-E580. PMID: 31133604. PMCID: PMC6538499.